论文信息 - Phase I Dose Escalation Study with Expansion Cohort of the Addition of Nab-Paclitaxel to Capecitabine and Oxaliplatin (CapOx) as First-Line Treatment of Metastatic Esophagogastric Adenocarcinoma (ACTION Study) - 字舞流文

Phase I Dose Escalation Study with Expansion Cohort of the Addition of Nab-Paclitaxel to Capecitabine and Oxaliplatin (CapOx) as First-Line Treatment of Metastatic Esophagogastric Adenocarcinoma (ACTION Study)

L. Beenen | M. V. van Oijen | C. Punt | G. Hooijer | S. Meijer | H. V. van Laarhoven | B. Mearadji | A. Creemers | M. Bijlsma | S. O. van der Woude | C. I. Stroes | C. Waasdorp | S. Schokker | J. V. van Kleef | R. Jibodh | Daan J van Zoen | Charlotte I Stroes | J. J. van Kleef